Compare STTK & UNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STTK | UNB |
|---|---|---|
| Founded | 2016 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | 99.3M |
| IPO Year | 2020 | 1998 |
| Metric | STTK | UNB |
|---|---|---|
| Price | $2.60 | $23.39 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 171.3K | 8.7K |
| Earning Date | 11-06-2025 | 01-14-2026 |
| Dividend Yield | N/A | ★ 6.37% |
| EPS Growth | N/A | ★ 27.30 |
| EPS | N/A | ★ 2.47 |
| Revenue | $1,000,000.00 | ★ $52,533,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.16 |
| Revenue Growth | N/A | ★ 13.25 |
| 52 Week Low | $0.69 | $20.65 |
| 52 Week High | $2.71 | $37.70 |
| Indicator | STTK | UNB |
|---|---|---|
| Relative Strength Index (RSI) | 71.07 | 53.28 |
| Support Level | $1.93 | $22.13 |
| Resistance Level | $2.18 | $23.58 |
| Average True Range (ATR) | 0.18 | 0.77 |
| MACD | 0.07 | 0.17 |
| Stochastic Oscillator | 97.78 | 89.84 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.